fbpx
Skip to main content
10/30/2017

Is a Low-FODMAP Diet the Next Big Thing?

Lately, it seems as though gluten is being blamed for a vast host of ailments – everything from irritable bowel syndrome (IBS) to attention-deficit disorder – with an ever increasing number of people seeking relief through a gluten-free diet. While this strict regimen is absolutely critical for people with a confirmed diagnosis of celiac disease,…

Continue Reading
10/2/2017

ImmusanT Finds Celiac Disease Might Be Diagnosed With A Single Gluten Challenge

ImmusanT, a clinical-stage company developing Nexvax2®, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet, presented data at the 2017 International Celiac Disease Symposium (ICDS) in Delhi, India for a potential blood test that could detect celiac disease with a single gluten challenge. This blood test could also…

Continue Reading
9/19/2017

How Will New FDA Strategies to Evaluate Benefits vs. Risks Impact Drug Development and Approval for Celiac Disease, Non-Celiac Gluten/Wheat Sensitivity, and Their Comorbidities?

On September 18, 2017, Celiac Disease Foundation (CDF) representatives attended a Food and Drug Administration (FDA) meeting in White Oak, MD on the ongoing implementation of a benefit-risk framework to inform drug and medical device review and approval processes. Under legislative mandate, the FDA is seeking to formally incorporate the patient experience and perspective into…

Continue Reading